Home > National Drug Code (NDC) > Butalbital, Aspirin, and Caffeine

Butalbital, Aspirin, and Caffeine - 0591-3219-01 - (butalbital, aspirin, and caffeine)

Alphabetical Index


Drug Information of Butalbital, Aspirin, and Caffeine

Product NDC: 0591-3219
Proprietary Name: Butalbital, Aspirin, and Caffeine
Non Proprietary Name: butalbital, aspirin, and caffeine
Active Ingredient(s): 325; 50; 40    mg/1; mg/1; mg/1 & nbsp;   butalbital, aspirin, and caffeine
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Butalbital, Aspirin, and Caffeine

Product NDC: 0591-3219
Labeler Name: Watson Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA017534
Marketing Category: NDA AUTHORIZED GENERIC
Start Marketing Date: 19760504

Package Information of Butalbital, Aspirin, and Caffeine

Package NDC: 0591-3219-01
Package Description: 100 CAPSULE in 1 BOTTLE (0591-3219-01)

NDC Information of Butalbital, Aspirin, and Caffeine

NDC Code 0591-3219-01
Proprietary Name Butalbital, Aspirin, and Caffeine
Package Description 100 CAPSULE in 1 BOTTLE (0591-3219-01)
Product NDC 0591-3219
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name butalbital, aspirin, and caffeine
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19760504
Marketing Category Name NDA AUTHORIZED GENERIC
Labeler Name Watson Laboratories, Inc.
Substance Name ASPIRIN; BUTALBITAL; CAFFEINE
Strength Number 325; 50; 40
Strength Unit mg/1; mg/1; mg/1
Pharmaceutical Classes Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient]

Complete Information of Butalbital, Aspirin, and Caffeine


General Information